1PB7 | A: | CRYSTAL STRUCTURE OF THE NR1 LIGAND BINDING CORE IN COMPLEX WITH GLYCINE AT 1.35 ANGSTROMS RESOLUTION |
1PB8 | A: | CRYSTAL STRUCTURE OF THE NR1 LIGAND BINDING CORE IN COMPLEX WITH D-SERINE AT 1.45 ANGSTROMS RESOLUTION |
1PB9 | A: | CRYSTAL STRUCTURE OF THE NR1 LIGAND BINDING CORE IN COMPLEX WITH D-CYCLOSERINE AT 1.60 ANGSTROMS RESOLUTION |
1PBQ | A:; B: | CRYSTAL STRUCTURE OF THE NR1 LIGAND BINDING CORE IN COMPLEX WITH 5,7-DICHLOROKYNURENIC ACID (DCKA) AT 1.90 ANGSTROMS RESOLUTION |
1Y1M | A:; B: | CRYSTAL STRUCTURE OF THE NR1 LIGAND BINDING CORE IN COMPLEX WITH CYCLOLEUCINE |
1Y1Z | A: | CRYSTAL STRUCTURE OF THE NR1 LIGAND BINDING CORE IN COMPLEX WITH ACBC |
1Y20 | A: | CRYSTAL STRUCTURE OF THE NR1 LIGAND-BINDING CORE IN COMPLEX WITH ACPC |
2A5T | A: | CRYSTAL STRUCTURE OF THE NR1/NR2A LIGAND-BINDING CORES COMPLEX |
4KCC | A: | CRYSTAL STRUCTURE OF THE NMDA RECEPTOR GLUN1 LIGAND BINDING DOMAIN APO STATE |
4KFQ | A:; B: | CRYSTAL STRUCTURE OF THE NMDA RECEPTOR GLUN1 LIGAND BINDING DOMAIN IN COMPLEX WITH 1-THIOXO-1,2-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]QUINOXALIN-4(5H)-ONE |
4NF4 | A: | CRYSTAL STRUCTURE OF GLUN1/GLUN2A LIGAND-BINDING DOMAIN IN COMPLEX WITH DCKA AND GLUTAMATE |
4NF5 | A: | CRYSTAL STRUCTURE OF GLUN1/GLUN2A LIGAND-BINDING DOMAIN IN COMPLEX WITH GLYCINE AND D-AP5 |
4NF6 | A: | CRYSTAL STRUCTURE OF GLUN1/GLUN2A LIGAND-BINDING DOMAIN IN COMPLEX WITH GLYCINE AND PPDA |
4NF8 | A: | CRYSTAL STRUCTURE OF GLUN1/GLUN2A LIGAND-BINDING DOMAIN IN COMPLEX WITH GLYCINE AND GLUTAMATE IN PEG2000MME |